The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women

American Journal of Epidemiology

Volumn 175, Issue 7, 2012, Pages 673-684

  Neuhouser, Marian L ^a   Manson, JoAnn E ^b   Millen, Amy ^c   Pettinger, Mary ^a   Margolis, Karen ^d   Jacobs, Elizabeth T ^e   Shikany, James M ^f   Vitolins, Mara ^g   Adams Campbell, Lucile ^h   Liu, Simin ⁱ   LeBlanc, Erin ^j   Johnson, Karen C ^k   Wactawski Wende, Jean ^c  

^a Fred Hutchinson Cancer Research Center   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^e UNIVERSITY OF ARIZONA   (United States)

^f University of Alabama at Birmingham   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

^h GEORGETOWN UNIVERSITY   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j CENTER FOR HEALTH RESEARCH   (United States)

^k UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

more..

Author keywords

25 hydroxyvitamin D; Breast neoplasms; Colorectal neoplasms; Postmenopausal women; Randomized controlled trials

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; VITAMIN D;

AGE CLASS; BLOOD; BODY MASS; CANCER; ETHNICITY; HEALTH IMPACT; HEALTH RISK; HEALTH STATUS; HEALTH SURVEY; LIFESTYLE; MULTIVARIATE ANALYSIS; NUMERICAL MODEL; SAMPLING; SERUM; VITAMIN; WOMENS HEALTH;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD ANALYSIS; BODY MASS; BREAST CANCER; CALCIUM INTAKE; CANCER HORMONE THERAPY; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; DRUG DOSE INCREASE; ETHNICITY; FEMALE; HUMAN; LATITUDE; LIFESTYLE; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; POSTMENOPAUSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); WAIST CIRCUMFERENCE;

AGE FACTORS; AGED; BODY MASS INDEX; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CONTINENTAL POPULATION GROUPS; FEMALE; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; LOGISTIC MODELS; MIDDLE AGED; MOTOR ACTIVITY; ODDS RATIO; RISK FACTORS; UNITED STATES; VITAMIN D;

EID: 84859510123     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwr350     Document Type: Article

References (51)

1. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet. 1989;1(8631):188-191. (Pubitemid 19038805)
2. Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr. 2007;85(6):1586-1591. (Pubitemid 46890428)
3. Garland CF, Garland FC. Do sunlight and vitamin D reduce the likelihood of colon cancer? Int J Epidemiol. 1980;9(3):227-231. (Pubitemid 11238851)
4. Lointier P, Wargovich MJ, Saez S, et al. The role of vitamin D3 in the proliferation of a human colon cancer cell line in vitro. Anticancer Res. 1987;7(4B):817-821.
5. Evans SR, Schwartz AM, Shchepotin EI, et al. Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1a,25-dihydroxy-16-ene- 23yne-26,27-hexafluoro-19-nor-cholecalciferol (Ro 25-6760), on a human colon cancer xenograft. Clin Cancer Res. 1998;4(11):2869-2876. (Pubitemid 28523517)
6. Meggouh F, Lointier P, Saez S. Sex steroid and 1,25-dihydroxyvitamin D3 receptors in human colorectal adenocarcinoma and normalmucosa. Cancer Res. 1991;51(4):1227-1233.
7. Pirianov G, Colston KW. Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells. Steroids. 2001;66(3-5):309-318. (Pubitemid 32140909)
8. International Agency for Research on Cancer. Vitamin D and Cancer. (IARC Working Group Reports, vol 5). Lyon, France: International Agency for Research on Cancer; 2008.
9. Millen AE, Pettinger M, Freudenheim JL, et al. Incident invasive breast cancer, geographic location of residence, and reported average time spent outside. Cancer Epidemiol Biomarkers Prev. 2009;18(2):495-507.
10. Millen AE, Wactawski-Wende J, Pettinger M, et al. Predictors of serum 25-hydroxyvitamin D concentrations among postmenopausal women: the Women's Health Initiative Calcium plus Vitamin D Clinical Trial. Am J Clin Nutr. 2010;91(5):1324-1335.
11. McCullough ML, Weinstein SJ, Freedman DM, et al. Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 2010;172(1):21-35.
12. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180-188.
13. Ross AC, Taylor CL, Yaktine AL, et al, eds. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
14. Women's Health Initiative Study Group. Design of the Women's Health Initiative Clinical Trial and Observational Study. Control Clin Trials. 1998;19(1):61-109.
15. Wactawski-Wende J, Kotchen JM, Anderson GL, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med. 2006;354(7):684-696. (Pubitemid 43247139)
16. Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. Women's Health Initiative Investigators. J Natl Cancer Inst. 2008;100(22):1581-1591.
17. Patterson RE, Kristal AR, Tinker LF, et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol. 1999;9(3):178-187. (Pubitemid 29144458)
18. Patterson RE, Levy L, Tinker LF, et al. Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative. Public Health Nutr. 1999;2(3):273-276. (Pubitemid 29446589)
19. Curb JD, McTiernan A, Heckbert SR, et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol. 2003;13(suppl 9):S122-S128. (Pubitemid 37324181)
20. Patterson RE, Kristal AR, Levy L, et al. Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol. 1998;148(7):643-649. (Pubitemid 28498431)
21. Gail MH, Costantino JP. Validating and improving models for projecting the absolute risk of breast cancer. J Natl Cancer Inst. 2001;93(5):334-335. (Pubitemid 32229370)
22. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(10):769-774. (Pubitemid 27435473)
23. Martínez ME, Giovannucci EL, Colditz GA, et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst. 1996;88(19):1375-1382. (Pubitemid 26329755)
24. Garland CF, Comstock GW, Garland FC, et al. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet. 1989;2(8673):1176-1178. (Pubitemid 19275448)
25. Cui Y, Rohan TE. Vitamin D, calcium, and breast cancer risk: a review. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1427-1437. (Pubitemid 44299311)
26. Bostick RM, Potter JD, Sellers TA, et al. Relation of calcium, vitamin D, and dairy food intake to incidence of colon cancer among older women. The Iowa Women's Health Study. Am J Epidemiol. 1993;137(12):1302-1317. (Pubitemid 23215031)
27. Kearney J, Giovannucci E, Rimm EB, et al. Calcium, vitamin D, and dairy foods and the occurrence of colon cancer in men. Am J Epidemiol. 1996;143(9):907-917. (Pubitemid 26131098)
28. Zheng W, Anderson KE, Kushi LH, et al. A prospective cohort study of intake of calcium, vitamin D, and other micronutrients in relation to incidence of rectal cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev. 1998;7(3):221-225. (Pubitemid 28353932)
29. McCullough ML, Robertson AS, Rodriguez C, et al. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control. 2003;14(1):1-12. (Pubitemid 36403263)
30. Feskanich D, Ma J, Fuchs CS, et al. Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004;13(9):1502-1508. (Pubitemid 39202318)
31. Braun MM, Helzlsouer KJ, Hollis BW, et al. Colon cancer and serum vitamin D metabolite levels 10-17 years prior to diagnosis. Am J Epidemiol. 1995;142(6):608-611.
32. Shin MH, Holmes MD, Hankinson SE, et al. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst. 2002;94(17):1301-1311.
33. McCullough ML, Rodriguez C, Diver WR, et al. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(12):2898-2904. (Pubitemid 43068822)
34. Anderson LN, Cotterchio M, Vieth R, et al. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr. 2010;91(6):1699-1707.
35. Robien K, Cutler GJ, Lazovich D. Vitamin D intake and breast cancer risk in postmenopausal women: the Iowa Women's Health Study. Cancer Causes Control. 2007;18(7):775-782. (Pubitemid 46988245)
36. Knight JA, Lesosky M, Barnett H, et al. Vitamin D and reduced risk of breast cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev. 2007;16(3):422-429. (Pubitemid 46548644)
37. Lowe LC, Guy M, Mansi JL, et al. Plasma 25-hydroxy vitamin D concentrations, vitamin D receptor genotype and breast cancer risk in a UK Caucasian population. Eur J Cancer. 2005;41(8):1164-1169. (Pubitemid 40725575)
38. Bertone-Johnson ER, Chen WY, Holick MF, et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1991-1997. (Pubitemid 41161213)
39. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer. 2011;128(6):1414-1424.
40. Goodwin PJ, Ennis M, Pritchard KI, et al. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol. 2009;27(23):3757-3763.
41. Jacobs ET, Thomson CA, Flatt SW, et al. Vitamin D and breast cancer recurrence in the Women's Healthy Eating and Living (WHEL) Study. Am J Clin Nutr. 2011;93(1):108-117.
42. Peters U, Hayes RB, Chatterjee N, et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team. Cancer Epidemiol Biomarkers Prev. 2004;13(4):546-552.
43. Platz EA, Hankinson SE, Hollis BW, et al. Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000;9(10):1059-1065.
44. Wei MY, Garland CF, Gorham ED, et al. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008;17(11):2958-2969.
45. Knight JA, Vachon CM, Vierkant RA, et al. No association between 25-hydroxyvitamin D and mammographic density. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1988-1992. (Pubitemid 44664279)
46. Neuhouser ML, Bernstein L, Hollis BW, et al. Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2010;19(2):412-417.
47. Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes. 2002;9(1):87-98. (Pubitemid 34747893)
48. Holick MF. Vitamin D. In: Stipanuk MH, ed. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia, PA: WB Saunders Company; 2000:624-636.
49. White E, Hunt JR, Casso D. Exposure measurement in cohort studies: the challenges of prospective data collection. Epidemiol Rev. 1998;20(1):43-56. (Pubitemid 28449752)
50. Armstrong BK, White E, Saracci R. Principles of Exposure Measurement in Epidemiology. Oxford, United Kingdom: Oxford University Press; 1992.
51. Jorde R, Sneve M, Hutchinson M, et al. Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study. Am J Epidemiol. 2010;171(8):903-908.